⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for advanced stage

Every month we try and update this database with for advanced stage cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %NCT04547504
Non-small-cell ...
Pembrolizumab
Pembrolizumab a...
18 Years - University Hospital, Brest
Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic AdenocarcinomaNCT00201838
Pancreatic Neop...
Adenocarcinoma
Gemcitabine
Etanercept
18 Years - Ohio State University Comprehensive Cancer Center
PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %NCT04547504
Non-small-cell ...
Pembrolizumab
Pembrolizumab a...
18 Years - University Hospital, Brest
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCCNCT05332821
Hepatocellular ...
PD-1/PD-L1 inhi...
TACE
18 Years - Zhongda Hospital
Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.NCT01291017
Non-small Cell ...
PD0332991
18 Years - University of Florida
Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)NCT05049044
Non-Small Cell ...
Quality of Life...
18 Years - Groupe Francais De Pneumo-Cancerologie
Iscar for Second Line Treatment of Advanced Non-Small Cell Lung CancerNCT00283478
Non-Small Cell ...
Iscar Quercus
Gemcitabine
18 Years - Kentuckiana Cancer Institute
Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural MesotheliomaNCT00535951
Carcinoma, Non-...
Mesothelioma
LBH589
18 Years - Novartis
Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic AdenocarcinomaNCT00201838
Pancreatic Neop...
Adenocarcinoma
Gemcitabine
Etanercept
18 Years - Ohio State University Comprehensive Cancer Center
PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %NCT04547504
Non-small-cell ...
Pembrolizumab
Pembrolizumab a...
18 Years - University Hospital, Brest
Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic AdenocarcinomaNCT00201838
Pancreatic Neop...
Adenocarcinoma
Gemcitabine
Etanercept
18 Years - Ohio State University Comprehensive Cancer Center
Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)NCT05049044
Non-Small Cell ...
Quality of Life...
18 Years - Groupe Francais De Pneumo-Cancerologie
BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLCNCT01156545
Non-small Cell ...
BIBW 2992
simvastatin
18 Years - National Cancer Center, Korea
First-line Combination Treatment Based on AnlotinibNCT03628521
Lung Cancer
Advanced Stage
Anlotinib,Erlot...
18 Years - 75 YearsShanghai Chest Hospital
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: